Teva Pharmaceutical

Teva Pharmaceutical Industries Ltd., founded in 1901, is a global leader in the pharmaceutical industry. With its headquarters in Petah Tikva, Israel, Teva has established a strong presence worldwide, focusing on the production and marketing of generic and specialty medicines. The company plays a pivotal role in improving patient health through its diverse portfolio of products and services.

Under the leadership of CEO Richard Francis, Teva continues to innovate and expand its offerings. The company excels in the development of biosimilars, providing cost-effective alternatives to expensive biologic drugs, thus increasing accessibility for patients. Additionally, Teva invests significantly in research and development to advance novel drug therapies and healthcare solutions.

Teva's commitment to quality and excellence is reflected in its comprehensive range of patient services and drug manufacturing capabilities. By leveraging its extensive expertise, Teva aims to address unmet medical needs and support healthcare systems globally. With a workforce of 35,000 employees, Teva remains dedicated to delivering high-quality, affordable medicines to patients around the world.